Federated Hermes

Federated Hermes’s Mersana Therapeutics MRSN Stock Holding History

Federated Hermes’s Portfolio MRSN Stock Details MRSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-7,349	Closed	-$263K	–	2147
2024 Q4	$263K	Sell	7,349 -1	-0%	-$52	﹤0.01%	1444
2024 Q3	$347K	Sell	7,350 -70	-0.9%	-$3.09K	﹤0.01%	1400
2024 Q2	$373K	Buy	7,420 +7,413	+105,900%	+$536K	﹤0.01%	1376
2024 Q1	$788	Buy	+7	New	+$696	﹤0.01%	1967
2023 Q4	–	Sell	-56	Closed	-$1.77K	–	2140
2023 Q3	$1.77K	Sell	56 -5,570	-99%	-$265K	﹤0.01%	1980
2023 Q2	$463K	Buy	+5,626	New	+$823K	﹤0.01%	1398
2022 Q2	–	Sell	-28,957	Closed	-$2.89M	–	2235
2022 Q1	$2.89M	Buy	28,957 +20,854	+257%	+$2.44M	0.01%	927
2021 Q4	$1.26M	Buy	+8,103	New	+$1.58M	﹤0.01%	1195
2021 Q1	–	Sell	-7	Closed	-$5K	–	2310
2020 Q4	$5K	Sell	7 -11,134	-100%	-$6.19M	﹤0.01%	2056
2020 Q3	$5.19M	Buy	11,141 +6,589	+145%	+$3.33M	0.01%	721
2020 Q2	$2.66M	Buy	4,552 +2,024	+80%	+$691K	0.01%	888
2020 Q1	$369K	Buy	+2,528	New	+$442K	﹤0.01%	1462
2019 Q4	–	Sell	-2	Closed	-$146	–	2121
2019 Q3	$1K	Buy	+2	New	+$145	﹤0.01%	2119

Other funds holding MRSN

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Schonfeld Strategic Advisors New York $12.3B AUM 37.17% 1-Year Est. Return

AQR Capital Management

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Silverarc Capital Management Boston, Massachusetts $849M AUM 470.8% 1-Year Est. Return

Acadian Asset Management

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return